(LNTH) - Earnings & Price History

LNTH: - 18.85, $741.40M, -1.05 (-5.28%)

Sector: N/A - Industry: N/A

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, an ultrasound contrast imaging agent for use in patients with suboptimal echocardiograms; TechneLite, a self-contained system or generator of technetium used in nuclear medicine procedures; and Xenon, a radiopharmaceutical gas used to assess pulmonary function, and imaging of cerebral blood flow. The company also offers injectable technetium-labeled imaging agents, including Cardiolite, used in myocardial perfusion imaging (MPI) procedures; and Neurolite, which is used to identify the area in the brain where blood flow has been blocked or reduced due to stroke. In addition, it provides injectable radiopharmaceutical imaging agents, such as Thallium Tl 201 t

Past LNTH reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-21AMC0.1312.159.35101012.56.95%21.50%29.95%1.79M
2016-11-01AMC0.079.59.059.559.059.955.52%▲-0.52%4.97%926.95K
2016-08-04AMC0.0663.894.24.26.37.97%42.86%54.24%1.79M
2016-05-03AMC0.061.971.942.41.942.4223.71%-17.92%1.55%182.27K
2016-02-22AMC0.022.332.042.962.272.9645.10%-21.28%14.22%63.88K
2015-11-040.044.253.313.753.654.2613.29%▲13.33%28.40%226.87K

Login | Register
Sunday Nov 19, 2017   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades